
Quotient Limited QTNT
Quarterly report 2022-Q4
added 02-09-2023
Quotient Limited Total Inventories 2011-2026 | QTNT
Annual Total Inventories Quotient Limited
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 22 M | 20.5 M | 15.6 M | 16.3 M | 13.6 M | 12.6 M | 4.61 M | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 22 M | 4.61 M | 15 M |
Quarterly Total Inventories Quotient Limited
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14.3 M | 12.8 M | 22.1 M | 22 M | 22.8 M | 25 M | 23.2 M | 23.2 M | 23.7 M | 23.7 M | 22.8 M | 21.3 M | 19.8 M | 18.1 M | 16.7 M | 15.6 M | 15.3 M | 15.3 M | 15.6 M | 16.3 M | 16.5 M | 15.2 M | 14.8 M | 13.6 M | 13.2 M | 13.4 M | 12.8 M | 12.6 M | 7.81 M | 5.83 M | 5.01 M | 4.61 M | 4.59 M | 4.42 M | 4.64 M | 4.56 M | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 25 M | 4.42 M | 15.1 M |
Total Inventories of other stocks in the Diagnostics research industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Agilent Technologies
A
|
830 M | $ 121.87 | 3.06 % | $ 37 B | ||
|
Burning Rock Biotech Limited
BNR
|
123 M | $ 20.67 | -8.13 % | $ 222 M | ||
|
Accelerate Diagnostics
AXDX
|
5.19 M | - | -61.36 % | $ 2.46 M | ||
|
Aspira Women's Health
AWH
|
256 K | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
757 K | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
7.72 M | - | 0.22 % | $ 16.8 M | ||
|
CareDx, Inc
CDNA
|
26.7 M | $ 21.42 | -4.46 % | $ 1.14 B | ||
|
DermTech
DMTK
|
1 M | - | -11.32 % | $ 2.94 M | ||
|
Enzo Biochem
ENZ
|
6.83 M | - | -8.98 % | $ 14.8 K | ||
|
Co-Diagnostics
CODX
|
992 K | $ 1.56 | 6.85 % | $ 2.08 M | ||
|
Exact Sciences Corporation
EXAS
|
166 M | - | - | $ 19.8 B | ||
|
Castle Biosciences
CSTL
|
8.14 M | $ 25.05 | 2.0 % | $ 696 M | ||
|
Global Cord Blood Corporation
CO
|
45.9 M | - | - | $ 399 M | ||
|
Charles River Laboratories International
CRL
|
299 M | $ 183.88 | 3.92 % | $ 9.11 B | ||
|
Danaher Corporation
DHR
|
2.49 B | $ 194.75 | 0.5 % | $ 139 B | ||
|
Interpace Biosciences
IDXG
|
1.11 M | $ 2.0 | -9.09 % | $ 8.85 M | ||
|
Myriad Genetics
MYGN
|
30.6 M | $ 5.08 | 1.6 % | $ 470 M | ||
|
Heska Corporation
HSKA
|
60 M | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
909 K | - | -20.0 % | $ 1.06 M | ||
|
NeoGenomics
NEO
|
28.6 M | $ 8.35 | 2.33 % | $ 1.07 B | ||
|
Neogen Corporation
NEOG
|
191 M | $ 9.51 | 2.92 % | $ 2.06 B | ||
|
Illumina
ILMN
|
547 M | $ 134.5 | 1.34 % | $ 21.4 B | ||
|
Precipio
PRPO
|
935 K | $ 28.3 | -2.41 % | $ 45.4 M | ||
|
Guardant Health
GH
|
85.9 M | $ 90.36 | 5.44 % | $ 11.3 B | ||
|
Senseonics Holdings
SENS
|
6.7 M | $ 6.77 | - | $ 282 M | ||
|
QIAGEN N.V.
QGEN
|
302 M | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
15 M | $ 52.78 | 0.4 % | $ 2.68 B | ||
|
Biomerica
BMRA
|
1.49 M | $ 2.18 | -0.91 % | $ 5.01 M | ||
|
Motus GI Holdings
MOTS
|
496 K | - | -34.28 % | $ 263 K | ||
|
ICON Public Limited Company
ICLR
|
2.3 M | $ 119.68 | 3.55 % | $ 9.87 B | ||
|
Laboratory Corporation of America Holdings
LH
|
535 M | $ 270.68 | 1.62 % | $ 22.5 B | ||
|
Neuronetics
STIM
|
4.33 M | $ 1.42 | 1.43 % | $ 93.7 M | ||
|
Lantheus Holdings
LNTH
|
64.7 M | $ 83.82 | -0.12 % | $ 5.66 B | ||
|
Thermo Fisher Scientific
TMO
|
5.42 B | $ 526.6 | 2.05 % | $ 199 B | ||
|
Quest Diagnostics Incorporated
DGX
|
189 M | $ 195.02 | 1.86 % | $ 21.6 B | ||
|
ENDRA Life Sciences
NDRA
|
2.62 M | $ 6.4 | 23.79 % | $ 5.04 M |